Equities

Zura Bio Ltd

Zura Bio Ltd

Actions
  • Price (EUR)4.18
  • Today's Change0.000 / 0.00%
  • Shares traded100.00
  • 1 Year change+18.08%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1000.010.73
Total Receivables, Net------
Total Inventory------
Prepaid expenses1.040.020.42
Other current assets, total------
Total current assets1010.031.15
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments--141139
Note receivable - long term------
Other long term assets------
Total assets101142141
LIABILITIES
Accounts payable2.750.280.07
Accrued expenses181.110.20
Notes payable/short-term debt00.360
Current portion long-term debt/capital leases------
Other current liabilities, total--0.080.00
Total current liabilities201.830.27
Total long term debt0.9900
Total debt0.990.360
Deferred income tax------
Minority interest20----
Other liabilities, total--5.9310
Total liabilities427.7610
SHAREHOLDERS EQUITY
Common stock0.00141139
Additional paid-in capital163----
Retained earnings (accumulated deficit)(103)(7.63)(9.18)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity59134130
Total liabilities & shareholders' equity101142141
Total common shares outstanding441717
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.